Unum Therapeutics (UMRX) IPO Opens Modestly Lower
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Unum Therapeutics Inc. (UMRX) Prices 5.77M Share IPO at $12/Sh
March 29, 2018 5:41 AM EDTUnum Therapeutics Inc. (NASDAQ: UMRX) (Unum Therapeutics), a clinical-stage biopharmaceutical company focused on the development of novel immunotherapy products designed to harness the power of a patients immune system to cure cancer, today announced the pricing of its initial public offering of 5,770,000... More
